Abbott India's profit jumped 24.1 per cent to Rs 287.1 crore in the March quarter of FY24 (Q4FY24), from Rs 231.4 crore in the March quarter of FY23 (Q4FY23)
The change could have financial implications for leading drug manufacturers like Abbott Laboratories, Bayer AG, and GlaxoSmithKline, among others
The company said it will begin production of EleCare and other specialty and metabolic formulas, with initial EleCare product release to consumers beginning on or about June 20
The demerger will give potential investors the option of being associated with the business of their choice
Drug major Abbott on Tuesday said it has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the prevention of postpartum haemorrhage (PPH)
(Reuters) -Abbott Laboratories' quarterly profit more than doubled on Thursday, due to strength in its diagnostics business and a rebound in medical device sales.
A decade after Piramal sold its domestic formulations business to Abbott Laboratories for $3.72 billion, the group is now looking at re-entering the space in India
Abbott to supply 50,000 tests a day starting April 1
The company had posted a profit of Rs 137.68 crore for the year-ago period, Abbott India said in a filing to BSE
Abbott's campaign uses real-life stories to convey its promise of creating breakthrough products
Drug maker Abbott will reimburse its trade partners for losses which could arise due to changes in the tax rate with the implementation of Goods and Service Tax from July 1.The move follows reports that stockists and distributors are keeping inventories to minimum and there are fears this could result in shortage of medicines in the market.In a note to its trade partners on Wednesday, Abbott said in case the new tax structure and the input claim process results into any loss to partner stockists on the closing inventory on June 30 or day preceding GST implementation, it will reimburse such value to the stockist. " This will ensure that our partner stockists do not suffer any loss resulting from tax structure changes on the inventory they hold," Abbott said. The company also requested its distributors to maintain normal inventory and ensure adequate availability of drugs during transition phase.GST will come into effect from July 1 and its implementation will change tax rate and ...
Abbott will now pay $51 per share for Alere, compared with its earlier offer of $56 per share